| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Daniel F Sansone last filed a Form 4 in June 2025, as Director at ASIX. The filings on record cover 2 companies. Daniel F Sansone's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 16,879 shares of NGVT.
Daniel F Sansone has 47 Form 4 filings on record from May 2016 to June 2025, across 2 companies: Director at AdvanSix (ASIX), 2016–2025; Director at Ingevity (NGVT), 2016–2025.
The 52 reported transactions were 44 stock awards, 6 gifts and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $211K and no sales.
The largest open-market purchase was 4,000 shares of ASIX at an average $27.37 on May 17, 2019, about $109K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.